Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence F Eichenfield

Showing results (291-300 of 377) with videos related to

Pageof 38
Sort By:
Journal of Patient-Reported Outcomes|July 18, 2019
Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitisLouise Newton, Amy M DeLozier, Philip C Griffiths, et al.
American Journal of Clinical Dermatology|February 8, 2026
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United StatesJonathan I Silverberg, David Cohen, Emma Guttman-Yassky, et al.
The Journal of Investigative Dermatology|August 15, 2025
Improving the quality of atopic dermatitis epidemiological research in the United States- A systematic review of disease definitions and related content in national surveysSarah L Becker, Gina N Bash, Wendy Smith Begolka, et al.
Allergy|March 3, 2025
Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic DermatitisAmy S Paller, Lawrence F Eichenfield, Alan D Irvine, et al.
Pediatric Dermatology|February 15, 2013
Therapeutic patient education in atopic dermatitis: worldwide experiencesJean-Francois Stalder, Claire Bernier, Alan Ball, et al.
BMJ Open|November 28, 2020
International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationaleKatrina Abuabara, Jonathan I Silverberg, Eric L Simpson, et al.
Pediatric Dermatology|March 23, 2023
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 studyLawrence F Eichenfield, Linda Stein Gold, Leon H Kircik, et al.
Journal of the American Academy of Dermatology|January 27, 2022
American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adultsDawn M R Davis, Aaron M Drucker, Ali Alikhan, et al.
Immunotherapy|February 27, 2025
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitisEmma Guttman-Yassky, Eric Simpson, Robert Bissonnette, et al.
American Journal of Clinical Dermatology|May 2, 2024
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 StudiesLawrence F Eichenfield, Eric L Simpson, Kim Papp, et al.
Pageof 38

Showing results (291-300 of 377) with videos related to

Sort By:
Pageof 38
Journal of Patient-Reported Outcomes|July 18, 2019
Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitisLouise Newton, Amy M DeLozier, Philip C Griffiths, et al.
American Journal of Clinical Dermatology|February 8, 2026
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United StatesJonathan I Silverberg, David Cohen, Emma Guttman-Yassky, et al.
The Journal of Investigative Dermatology|August 15, 2025
Improving the quality of atopic dermatitis epidemiological research in the United States- A systematic review of disease definitions and related content in national surveysSarah L Becker, Gina N Bash, Wendy Smith Begolka, et al.
Allergy|March 3, 2025
Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic DermatitisAmy S Paller, Lawrence F Eichenfield, Alan D Irvine, et al.
Pediatric Dermatology|February 15, 2013
Therapeutic patient education in atopic dermatitis: worldwide experiencesJean-Francois Stalder, Claire Bernier, Alan Ball, et al.
BMJ Open|November 28, 2020
International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationaleKatrina Abuabara, Jonathan I Silverberg, Eric L Simpson, et al.
Pediatric Dermatology|March 23, 2023
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 studyLawrence F Eichenfield, Linda Stein Gold, Leon H Kircik, et al.
Journal of the American Academy of Dermatology|January 27, 2022
American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adultsDawn M R Davis, Aaron M Drucker, Ali Alikhan, et al.
Immunotherapy|February 27, 2025
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitisEmma Guttman-Yassky, Eric Simpson, Robert Bissonnette, et al.
American Journal of Clinical Dermatology|May 2, 2024
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 StudiesLawrence F Eichenfield, Eric L Simpson, Kim Papp, et al.
Pageof 38